A Study of Ocrelizumab in Participants With Relapsing Remitting Multiple Sclerosis (RRMS) Who Have Had a Suboptimal Response to an Adequate Course of Disease-Modifying Treatment (DMT)

NCT ID: NCT02861014

Last Updated: 2022-01-27

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

PHASE3

Total Enrollment

681 participants

Study Classification

INTERVENTIONAL

Study Start Date

2016-09-09

Study Completion Date

2020-12-15

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this prospective, multicenter, open-label, efficacy, and safety study is to assess the efficacy and safety of ocrelizumab in participants with Relapsing Remitting Multiple Sclerosis (RRMS) who have had a suboptimal response to an adequate course of a Disease-Modifying Treatment (DMT). The study will consist of a Screening period (up to 4 weeks), an Open-label treatment period (96 weeks; with last dose administered at Week 72), and a Follow-up period of at least 2 years.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Multiple Sclerosis, Relapsing-Remitting

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Ocrelizumab

Ocrelizumab will be administered as two 300 mg IV infusions on Days 1 and 15 followed by one 600 mg IV infusions administered at Weeks 24, 48, and 72.

Group Type EXPERIMENTAL

Ocrelizumab

Intervention Type BIOLOGICAL

Ocrelizumab will be administered as two 300 mg IV infusions on Days 1 and 15 followed by one 600 mg IV infusions administered at Weeks 24, 48, and 72.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Ocrelizumab

Ocrelizumab will be administered as two 300 mg IV infusions on Days 1 and 15 followed by one 600 mg IV infusions administered at Weeks 24, 48, and 72.

Intervention Type BIOLOGICAL

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

RO4964913

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Have a definite diagnosis of RRMS, confirmed as per the revised McDonald 2010 criteria
* Have a length of disease duration, from first symptom, of less than (\<) 10 years
* Have received no more than two prior DMTs, and the discontinuation of the most recent DMT was due to lack of efficacy
* Suboptimal disease control while on a DMT
* Expanded Disability Status Scale (EDSS) of 0.0 to 4.0, inclusive, at Screening
* For women of childbearing potential: agreement to use an acceptable birth control method during the treatment period and for at least 6 months after the last dose of study drug

Exclusion Criteria

* Secondary progressive multiple sclerosis (SPMS) or history of primary progressive or progressive relapsing multiple sclerosis (MS)
* Inability to complete an Magnetic Resonance Imaging (MRI) procedure
* Known presence of other neurological disorders
* Any concomitant disease that may require chronic treatment with systemic corticosteroids or immunosuppressants during the course of the study
* History or currently active primary or secondary immunodeficiency
* History of severe allergic or anaphylactic reactions to humanized or murine monoclonal antibodies
* History of opportunistic infections
* History or known presence of recurrent or chronic infection
* History of malignancy
* Congestive heart failure
* Known active bacterial, viral, fungal, mycobacterial infection or other infection, excluding fungal infection of nail beds
Minimum Eligible Age

18 Years

Maximum Eligible Age

55 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Hoffmann-La Roche

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Clinical Trials

Role: STUDY_DIRECTOR

Hoffmann-La Roche

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

St George Hospital

Kogarah, New South Wales, New South Wales, Australia

Site Status

Hospital Erasme

Brussels, , Belgium

Site Status

Cliniques Universitaires St-Luc

Brussels, , Belgium

Site Status

UZ Antwerpen

Edegem, , Belgium

Site Status

UZ Gent

Ghent, , Belgium

Site Status

CHU Tivoli

La Louvière, , Belgium

Site Status

UZ Leuven Gasthuisberg

Leuven, , Belgium

Site Status

Nationaal MS Centrum

Melsbroek, , Belgium

Site Status

Revalidatie en MS Centrum

Overpelt, , Belgium

Site Status

Fakultni nemocnice u sv. Anny; Neurologicka klinika

Brno, , Czechia

Site Status

Nemocnice Jihlava; NEU-Neurologicke oddeleni

Jihlava, , Czechia

Site Status

VFN Praha Poliklinika Rs Centrum - Budova A

Prague, , Czechia

Site Status

Fakultni nemocnice Motol; Neurologicka klinika

Prague, , Czechia

Site Status

Aarhus Universitetshospital, Neurologisk Afd. F, Skleroseklinikken

Aarhus N, , Denmark

Site Status

Rigshospitalet Glostrup; Neurologisk Klinik

Glostrup Municipality, , Denmark

Site Status

Odense Universitetshospital, Neurologisk Afdeling N

Odense C, , Denmark

Site Status

Sydjysk Skleroseklinik - Sønderborg

Sønderborg, , Denmark

Site Status

East Tallinn Central Hospital; Neurology Department

Tallinn, , Estonia

Site Status

West Tallinn Central Hospital

Tallinn, , Estonia

Site Status

Tartu University Hospital

Tartu, , Estonia

Site Status

Terveystalo Tampere

Tampere, , Finland

Site Status

Mehiläinen Neo Turku

Turku, , Finland

Site Status

CHU de Besancon Hopital Jean Minjoz; Service de Neurologie

Besançon, , France

Site Status

Groupe Hospitalier Pellegrin; Service de neurochirurgie B

Bordeaux, , France

Site Status

Hopital Neurologique et Neurochirurgical Pierre Wertheimer; Service de Neurologie A

Bron, , France

Site Status

Hopital Gabriel Montpied CHU de Clermont-Ferrand; Service de Neurologie B

Clermont-Ferrand, , France

Site Status

Hopital Roger Salengro; Service de Neurologie

Lille, , France

Site Status

CHU de la Timone - Hopital d Adultes; Service de Neurologie

Marseille, , France

Site Status

Hopital Gui de Chauliac; Neurologie

Montpellier, , France

Site Status

Hôpital Guillaume et René Laënnec; Service Neurologie

Nantes, , France

Site Status

Hôpital Pasteur; Service de Neurologie

Nice, , France

Site Status

Fondation Rothschild; Service de Neurologie

Paris, , France

Site Status

Groupe Hospitalier Pitié- Salpétrière; Service Neurologie

Paris, , France

Site Status

Hôpital Maison Blanche; Service de Neurologie

Reims, , France

Site Status

Hôpitaux Universitaires de strasbourg - hôpital civil

Strasbourg, , France

Site Status

CHU toulouse - Hôpital Purpan; Departement de Neurologie

Toulouse, , France

Site Status

CHRU - Hôpital Bretonneau; Neurologie

Tours, , France

Site Status

Klinikum Augsburg, Neurologische Klinik und klinische Neurophysiologie

Augsburg, , Germany

Site Status

Marianne-Strauß-Klinik; Behandlung Kempfen für Multip Sklero Kranke gemeinnütz GmbH

Berg, , Germany

Site Status

Charite - Universitatsmedizin Berlin; Klinik fur Neurologie

Berlin, , Germany

Site Status

Praxis Dr. Said Masri

Berlin, , Germany

Site Status

Gemeinschaftspraxis Dr.med. Reinhard Ehret/Dr. med Wolfram von Pannwitz

Berlin, , Germany

Site Status

Jüdisches Krankenhaus Berlin; Abteilung fur Neurologie

Berlin, , Germany

Site Status

St. Josef-Hospital, Klinik für Neurologie

Bochum, , Germany

Site Status

Gesundheitszentrum St. Johannes Hospital; Neurolog. Gemeinschaftspraxis Dres. Schmidt, Neudecker etc

Bonn, , Germany

Site Status

Studienzentrum für Neurologie und Psychiatrie

Böblingen, , Germany

Site Status

PNP Buchholz, Praxis für Neurologie - Psychiatrie, Dres. Dee/Gößling/Hoge

Buchholz, , Germany

Site Status

Universitätsklinikum "Carl Gustav Carus", Zentrum für Klinische Neurowissenschaften

Dresden, , Germany

Site Status

Gemeinschaftspraxis für Neurologie; Dr. Katrin Schulte, Dr. Nils Richter, Dr. Margarete Capito

Düsseldorf, , Germany

Site Status

NeuroCentrum Odenwald; Dres. Reifschneider, Unsorg, Ries, Schumann, Hoffmann, Knoblich

Erbach/Odenwald, , Germany

Site Status

Universitaetsklinikum Frankfurt; Klinik für Neurologie

Frankfurt, , Germany

Site Status

Universitätsklinikum Freiburg, Klinik für Neurologie und Neurophysiologie

Freiburg im Breisgau, , Germany

Site Status

Universiätsklinikum Hamburg-Eppendorf , Multiple Sklerose Tagesklinik u. Ambulanz Neurol. Poliklinik

Hamburg, , Germany

Site Status

Neurologische Praxisgemeinschaft Hamburger-Straße; Dres. Müller-Habich/Emrich/Vogt

Hamburg, , Germany

Site Status

MultipEL Studies - Institut für klinische Studien

Hamburg, , Germany

Site Status

Henriettenstiftung Hannover; Klinik fuer Neurologie und Klinische Neurophysiologie

Hanover, , Germany

Site Status

Neurologische Klinik, Universitätsklinikum Heidelberg

Heidelberg, , Germany

Site Status

Oberhavel Kliniken GmbH, Klinik Hennigsdorf, Neurologie

Hennigsdorf, , Germany

Site Status

Neurozentrum am Klosterforst in Itzehoe

Itzehoe, , Germany

Site Status

Neurologische Gemeinschaftspraxis Kassel und Vellmar, Ch. Lassek, Dres. Ammerbach, Fetzer, M. Fische

Kassel, , Germany

Site Status

PANAKEIA - Arzneimittelforschung Leipzig GmbH

Leipzig, , Germany

Site Status

Universitätsklinikum Magdeburg,Otto-von-Guericke-Universität A.ö.R., Klinik für Neurologie

Magdeburg, , Germany

Site Status

Universitaetsklinikum Mainz - PS; Klinik und Poliklinik fuer Neurologie

Mainz, , Germany

Site Status

Universitaetsklinikum Marburg; Klinik fuer Neurologie

Marburg, , Germany

Site Status

Max-Planck-Institut für Psychiatrie

München, , Germany

Site Status

Klinikum Grosshadern der LMU; Neuroimmunologie II

München, , Germany

Site Status

Klinikum rechts der Isar der TU Muenchen; Neurologische Klinik und Poliklinik im Neuro-Kopf-Zentrum

München, , Germany

Site Status

Universitätsklinikum Münster; Klinik und Poliklinik für Neurologie

Münster, , Germany

Site Status

Ruppiner Kliniken, Hochschulklinikum der Medizinischen Hochschule Brandenburg, Klinik für Neurologie

Neuruppin, , Germany

Site Status

AMEOS Klinikum Oldenburg, Klinik für Neurologie und Neurophysiologie

Oldenburg in Holstein, , Germany

Site Status

St. Josefs-Krankenhaus, Klinik für Neurologie

Potsdam, , Germany

Site Status

NeuroConcept AG C/O mind mvz GmbH

Stuttgart, , Germany

Site Status

Universitätsklinikum Tübingen, Zentrum für Neurologie

Tübingen, , Germany

Site Status

NeuroPoint, Gesellschaft für vorbeugende Gesundheitspflege mbH

Ulm, , Germany

Site Status

Studienzentrum Nordwest, Dr. med. Joachim Springub / Herr Wolfgang Schwarz

Westerstede, , Germany

Site Status

Cork University Hospital; Clinical Research Facility

Cork, , Ireland

Site Status

Beaumont Hospital

Dublin, , Ireland

Site Status

St Vincents University Hospital

Dublin, , Ireland

Site Status

Ospedale SS. Annunziata - Clinica Neurologica - Centro Sclerosi Multipla

Chieti, Abruzzo, Italy

Site Status

Ospedale San Salvatore; Clinica Neurologica - Centro Sclerosi Multipla

L’Aquila, Abruzzo, Italy

Site Status

Ospedale Dimiccoli Barletta; Dipartimento Testa-Collo - UO Neurologia

Barletta, Apulia, Italy

Site Status

IRCCS Ospedale Casa Sollievo Della Sofferenza; SC Neurologia

San Giovanni Rotondo, Apulia, Italy

Site Status

A. O. U. Federico II; Dip Neuroscienze, Scienze Riproduttive ed Odontostomatologiche

Napoli, Campania, Italy

Site Status

Università degli Studi della Campania Luigi Vanvitelli; Dip. Ass. Integrato Med Int-II Clinica Neur

Napoli, Campania, Italy

Site Status

Ospedale Bellaria; Istituto delle Scienze Neurologiche - UO RIABILITAZIONE SCLEROSI MULTIPLA

Bologna, Emilia-Romagna, Italy

Site Status

Policlinico Tor Vergata Dip. Neuroscienze-Clinica Neurologica-UOSD Sclerosi Multipla

Rome, Lazio, Italy

Site Status

Ospedale S.Camillo Forlanini; UOSD Day Hospital Neurologico e Neurochirurgico

Rome, Lazio, Italy

Site Status

Policlinico Universitario A. Gemelli; UOC Neurologia - Centro Sclerosi Multipla

Rome, Lazio, Italy

Site Status

Azienda Ospedaliera Sant'Andrea; UOC Neurologia

Rome, Lazio, Italy

Site Status

Irccs A.O.U.San Martino Ist; Dinogmi

Genoa, Liguria, Italy

Site Status

ASST PAPA GIOVANNI XXIII Neurologia USS Malattie Autoimmuni Centro Sclerosi Multipla

Bergamo, Lombardy, Italy

Site Status

Ospedale S.Antonio Abate; Neurologia 2 - Sclerosi Multipla e Recupero Neurologico

Gallarate, Lombardy, Italy

Site Status

Fondazione IRCCS Ca' Granda - Ospedale Maggiore Policlinico; UOSD Malattie Neurodegenerative

Milan, Lombardy, Italy

Site Status

IRCCS Ospedale San Raffaele; Neurologia Neurofisiologia Neuroriabilitazione-Centro Sclerosi Multipla

Milan, Lombardy, Italy

Site Status

Fond. Istituto Neurologico C.Besta; UO Neurologia IV - Neuroimmunologia Malattie Neuromuscolari

Milan, Lombardy, Italy

Site Status

Ospedale Civile di Montichiari; Centro Sclerosi Multipla

Montichiari, Lombardy, Italy

Site Status

IRCCS Istituto Neurologico C. Mondino-Dip. Neurologia Neuroriabilitazione S.S. Sclerosi Multipla

Pavia, Lombardy, Italy

Site Status

IRCCS Istituto Neurologico Neuromed; Centro per lo Studio e la Cura della Sclerosi Multipla

Pozzilli, Molise, Italy

Site Status

Ospedale Binaghi; Centro Sclerosi Multipla

Cagliari, Sardinia, Italy

Site Status

AOU Policlinico V. Emanuele - P.O G. Rodolico; Clinica Neurologica, Centro Sclerosi Multipla

Catania, Sicily, Italy

Site Status

Fondazione Istituto S. Raffaele - Giglio; UO Neurologia

Cefalù, Sicily, Italy

Site Status

AOU Policlinico Giaccone; UOC Neurologia e Neurofisiopatologia-Amb Sclerosi Multipla

Palermo, Sicily, Italy

Site Status

AO Ospedali Riuniti Villa Sofia-Cervello;PO Villa Sofia - UO Neurologia - U.O.S. Neuroimmunologia

Palermo, Sicily, Italy

Site Status

AOU Ospedali Riuniti Umberto I-G.M. Lancisi-G. Salesi; SOD Clinica Neurologica-Am.Sclerosi Multipla

Ancona, The Marches, Italy

Site Status

AOU Careggi; Neurologia 1-Dip. Neuroscienze Psicologia Area Farmaco Salute del Bambino(NEUROFARBA)

Florence, Tuscany, Italy

Site Status

AOUC Azienda Ospedaliero-Universitaria Careggi; Neurologia 2

Florence, Tuscany, Italy

Site Status

AOU Senese - Presidio Ospedaliero Le Scotte; UOSA Neurologia Sperimentale

Siena, Tuscany, Italy

Site Status

AO di Perugia - Ospedale S. Maria della Misericordia; Clinica Neurologica

Perugia, Umbria, Italy

Site Status

Azienda Ospedaliera di Padova; Clinica Neurologica

Padua, Veneto, Italy

Site Status

Policlinico G.B. Rossi; Dip. Scienze Neurologiche Biomediche - Neurologia B - Amb. Sclerosi Multipla

Verona, Veneto, Italy

Site Status

Amphia Ziekenhuis

Breda, , Netherlands

Site Status

St. Antonius Ziekenhuis Nieuwegein

Nieuwegein, , Netherlands

Site Status

Maasstadziekenhuis

Rotterdam, , Netherlands

Site Status

Zuyderland Medisch Centrum - Sittard Geleen

Sittard-Geleen, , Netherlands

Site Status

Sint Elizabeth Ziekenhuis

Tilburg, , Netherlands

Site Status

Haukeland Universitetssykehus

Bergen, , Norway

Site Status

Sykehuset Buskerud HF; Nevrologisk avdeling

Drammen, , Norway

Site Status

Hospital Universitari de Bellvitge; Servicio de Neurologia

L'Hospitalet de Llobregat, Barcelona, Spain

Site Status

Hospital General de Castellon; Servicio de Neurología

Castellon, Castellon, Spain

Site Status

Hospital Universitari de Girona Dr. Josep Trueta; Servicio de Neurologia

Salt, Girona, Spain

Site Status

Complejo Hospitalario Universitario A Coruña (CHUAC); Servicio de Neurologia

A Coruña, LA Coruña, Spain

Site Status

Hospital Universitari Arnau de Vilanova de Lleida; Servicio de Neurología

Lleida, Lerida, Spain

Site Status

Hospital Quiron de Madrid; Servicio de Neurologia

Pozuelo de Alarcón, Madrid, Spain

Site Status

Complejo Hospitalario Universitario de Vigo - Xeral Cies; Servicio de Neurologia

Vigo, Pontevedra, Spain

Site Status

Hospital Universitario Central de Asturias; Servicio de Neurología

Oviedo, Principality of Asturias, Spain

Site Status

Hospital del Mar; Servicio de Neurologia

Barcelona, , Spain

Site Status

Hospital Vall d'Hebron; Servicio de Neurología

Barcelona, , Spain

Site Status

Hospital Puerta del Mar; Sevicio de Neurologia

Cadiz, , Spain

Site Status

Universitario de La Princesa; Servicio de Neurología

Madrid, , Spain

Site Status

Hospital Universitario Clínico San Carlos; Servicio de Neurología

Madrid, , Spain

Site Status

Hospital Universitario 12 de Octubre; Servicio de Neurologia

Madrid, , Spain

Site Status

Hospital Universitario La Paz; Servicio de Neurologia

Madrid, , Spain

Site Status

Hospital Universitario Virgen de Arrixaca; Servicio de Neurología

Murcia, , Spain

Site Status

Hospital Universitario Virgen Macarena; Servicio de Neurologia

Seville, , Spain

Site Status

Hospital Clinico Universitario de Valencia; Servicio de Neurologia

Valencia, , Spain

Site Status

Hospital Universitario la Fe; Servicio de Neurologia

Valencia, , Spain

Site Status

Sahlgrenska Sjukhuset; Neurology

Gothenburg, , Sweden

Site Status

Länssjukhuset Ryhov; Medicinkliniken / Neurologmottagningen

Jönköping, , Sweden

Site Status

Centrum för Neurologi

Stockholm, , Sweden

Site Status

Universitätsspital Basel Medizin Neurologie; Neurologische Poliklinik

Basel, , Switzerland

Site Status

CHUV Lausanne Méd.Neurologie

Lausanne, , Switzerland

Site Status

Hacettepe University Medical Faculty; Neurology

Ankara, , Turkey (Türkiye)

Site Status

Istanbul Uni Istanbul Medical Faculty

Istanbul, , Turkey (Türkiye)

Site Status

Istanbul Universitesi - Cerrahpasa Cerrahpasa Tip Fakultesi; Noroloji Anabilim Dali

Istanbul, , Turkey (Türkiye)

Site Status

Ege University Medical Faculty

Izmir, , Turkey (Türkiye)

Site Status

Kocaeli University Hospital; Department of Neurology

Kocaeli, , Turkey (Türkiye)

Site Status

Mersin University Medical Faculty; Neurology

Mersin, , Turkey (Türkiye)

Site Status

Ondokuz Mayis Univ. Med. Fac.; Neurology

Samsun, , Turkey (Türkiye)

Site Status

Karadeniz Tecnical Uni. Med. Fac.; Neurology

Trabzon, , Turkey (Türkiye)

Site Status

New Queen Elizabeth Hospital Birmingham

Birmingham, , United Kingdom

Site Status

Western General Hospital

Edinburgh, , United Kingdom

Site Status

Royal Devon and Exeter Hospital (Wonford)

Exeter, , United Kingdom

Site Status

Queen Elizabeth University Hospital

Glasgow, , United Kingdom

Site Status

Raigmore Hospital

Inverness, , United Kingdom

Site Status

Leeds Teaching Hospitals NHS Trust

Leeds, , United Kingdom

Site Status

The Royal London Hospital

London, , United Kingdom

Site Status

Kings College Hospital

London, , United Kingdom

Site Status

Charing Cross Hospital

London, , United Kingdom

Site Status

Royal Victoria Infirmary

Newcastle upon Tyne, , United Kingdom

Site Status

Salford Royal NHS Foundation Trust

Salford, , United Kingdom

Site Status

Royal Hallamshire Hospita

Sheffield, , United Kingdom

Site Status

Morriston Hospital

Swansea, , United Kingdom

Site Status

Royal Cornwall Hospital

Truro, , United Kingdom

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Australia Belgium Czechia Denmark Estonia Finland France Germany Ireland Italy Netherlands Norway Spain Sweden Switzerland Turkey (Türkiye) United Kingdom

References

Explore related publications, articles, or registry entries linked to this study.

Vermersch P, Oreja-Guevara C, Siva A, Van Wijmeersch B, Wiendl H, Wuerfel J, Buffels R, Kadner K, Kuenzel T, Comi G; CASTING Investigators. Efficacy and safety of ocrelizumab in patients with relapsing-remitting multiple sclerosis with suboptimal response to prior disease-modifying therapies: A primary analysis from the phase 3b CASTING single-arm, open-label trial. Eur J Neurol. 2022 Mar;29(3):790-801. doi: 10.1111/ene.15171. Epub 2021 Nov 25.

Reference Type DERIVED
PMID: 34748672 (View on PubMed)

Provided Documents

Download supplemental materials such as informed consent forms, study protocols, or participant manuals.

Document Type: Study Protocol

View Document

Document Type: Statistical Analysis Plan

View Document

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2015-005597-38

Identifier Type: EUDRACT_NUMBER

Identifier Source: secondary_id

MA30005

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Effects of Ocrevus in Relapsing Multiple Sclerosis
NCT04387734 ACTIVE_NOT_RECRUITING PHASE4